Connor Iapoce is an associate editor for HCPLive and joined the MJH Life Sciences team in April 2021. He graduated from The College of New Jersey with a degree in Journalism and Professional Writing. He enjoys listening to records, going to concerts, and playing with his cat Squish. You can reach him at ciapoce@mjhlifesciences.com.
FDA Accepts BLA for Aflibercept 8mg for Priority Review
February 24th 2023The BLA for Regeneron's wet AMD and DME treatment was supported by two pivotal trials demonstrating non-inferior vision gains to aflibercept Injection, with most patients maintaining extended dosing regimens through 48 weeks
Read More
Charles Wykoff, MD, PhD: Significance of the Pegcetacoplan Approval for GA
February 22nd 2023The historic FDA approval of pegcetacoplan marks the first and only approved treatment for geographic atrophy. In a new interview, Dr. Wykoff expresses what approval means for patients with the debilitating disease.
Read More
Infants with Acute ROP Remain at Risk of Vision-Threatening Outcomes in Later Life
February 19th 2023Investigators stress the need for timely surgical intervention to ensure favorable visual outcomes in patients with severe complications, including retinal detachment and vitreous hemorrhage.
Read More
Optic Disc Features Associated with Grey Crescent Risk in Glaucoma
February 18th 2023Investigators from the University of Pennsylvania suggest the associations, particularly beta peripapillary atrophy, and tilted optic discs, should be accounted for when investigating glaucoma in high-risk black populations.
Read More
Glaucoma-Related Adverse Events Common After Pediatric Lensectomy
February 16th 2023Age less than 3 months at surgery was associated with an elevated risk of glaucoma-related adverse events in aphakic eyes, but children with pseudophakia were less likely to develop a glaucoma-related adverse event.
Read More
Stress-Induced Burnout Observed Among Cataract Surgeons
February 15th 2023A nationwide study from the United Kingdom identified a low overall prevalence of stress-induced burnout by cataract surgery but reported a reduction in the feelings of personal achievement and a significant proportion willing to give up surgical responsibilities.
Read More
Mental Health Measures Varied by Glaucoma Status During COVID-19 Pandemic
February 15th 2023An analysis of the NIH All of Us Research Program suggests patients with glaucoma did not fare worse during the early stages of the COVID-19 pandemic, but still endured stress, social isolation, and probable depression.
Read More
Low-Concentration Atropine Eyedrops Linked to Lower Myopia Incidence in Children
February 14th 2023Results of the LAMP2 trial indicate a delay of myopia onset and progression, rather than prevention, with 0.05% atropine eyedrop use, leading study investigators to call for further research.
Read More
Newly Diagnosed T2D Subtypes Show No Difference in Retinal Microvascular Structure
February 10th 2023A multivariate linear mixed model regression analysis of eyes without DR indicates no statistically significant differences in retinal venular or arteriolar width between subtypes and patients with classical T2D.
Read More